Literature DB >> 2989767

Parallel changes in red blood cell and renal Na-K-ATPase activity in adrenal and electrolyte disorders in the rat.

H Wald, P Scherzer, M M Popovtzer.   

Abstract

To compare the activity of Na-K-ATPase in the red blood cells (RBCs) and in renal tissue in disorders of Na+ metabolism, the following groups of rats were studied: 1) control, intact rats, 2) adrenalectomized (ADX) rats, 3) intact rats treated with DOCA, 4) ADX DOCA-treated rats, 5) intact salt-loaded rats, 6) ADX salt-loaded rats, 7) intact dexamethasone-treated rats (DEXA), and 8) ADX DEXA-treated rats. After adrenalectomy (group 2) serum Na+ decreased and serum K+ increased. Renal Na-K-ATPase in cortex, medulla and papilla of the control group was 44 +/- 2.7 mumol Pi/mg prot/h, 128.2 +/- 5.9 and 44 +/- 3.2 respectively and in group 2 the enzyme activity was 32.5 +/- 2.0 (P less than 0.005), 81.7 +/- 4.5 (P less than 0.001) and 23.6 +/- 1.9 (P less than 0.001) respectively. RBCs Na-K-ATPase of control animals was 2.82 +/- 0.19 mumol Pi/mg prot/h, while in group 2 the activity was 1.43 +/- 0.24 (P less than 0.001). DOCA treatment of ADX rats (group 4) normalized serum electrolytes and Na-K-ATPase activity in the renal cortex and papilla and in the RBCs. In the renal medulla the correction by DOCA was only partial. Salt loading of ADX rats (group 6) normalized serum electrolytes and Na-K-ATPase activity in the renal medulla and RBCs. Salt loading of normal rats increased RBC Na-K-ATPase to 3.72 +/- 0.36 (P less than 0.02) and medullary Na-K-ATPase to 185.6 +/- 9.8 (P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989767     DOI: 10.1007/bf00581491

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  22 in total

1.  The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.

Authors:  J T DODGE; C MITCHELL; D J HANAHAN
Journal:  Arch Biochem Biophys       Date:  1963-01       Impact factor: 4.013

Review 2.  The sodium-potassium adenosinetriphosphatase.

Authors:  J L Dahl; L E Hokin
Journal:  Annu Rev Biochem       Date:  1974       Impact factor: 23.643

3.  Na-K-ATPase in sodium transport by the perfused rat kidney.

Authors:  B Ross; A Leaf; P Silva; F H Epstein
Journal:  Am J Physiol       Date:  1974-03

4.  Effects of adrenalectomy and hormone replacement on Na- K-ATPase in renal tissue.

Authors:  E D Hendler; J Torretti; L Kupor; F H Epstein
Journal:  Am J Physiol       Date:  1972-03

5.  The (Na++K+) activated enzyme system and its relationship to transport of sodium and potassium.

Authors:  J C Skou
Journal:  Q Rev Biophys       Date:  1974-07       Impact factor: 5.318

6.  Preparation of highly active (Na+ + K+)-ATPase from the outer medulla of rabbit kidney.

Authors:  P L Jorgensen; J C Skou
Journal:  Biochem Biophys Res Commun       Date:  1969-09-24       Impact factor: 3.575

7.  Regulation of the (Na+ + K+)-activated ATP hydrolyzing enzyme system in rat kidney. I. The effect of adrenalectomy and the supply of sodium on the enzyme system.

Authors:  P L Jorgensen
Journal:  Biochim Biophys Acta       Date:  1968-01-08

8.  Effect of aldosterone on the human erythrocyte sodium--potassium pump in vitro.

Authors:  N Stern; F Beck; J Sowers
Journal:  Clin Sci (Lond)       Date:  1983-02       Impact factor: 6.124

9.  Effect of chronic salt loading on renal Na-K-ATPase activity in the rat.

Authors:  H Wald; F H Epstein; M M Popovtzer
Journal:  Proc Soc Exp Biol Med       Date:  1983-03

10.  Secondary effect of aldosterone on Na-KATPase activity in the rabbit cortical collecting tubule.

Authors:  K J Petty; J P Kokko; D Marver
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

View more
  1 in total

1.  (Pro)Renin receptor regulates potassium homeostasis through a local mechanism.

Authors:  Chuanming Xu; Aihua Lu; Hong Wang; Hui Fang; Li Zhou; Peng Sun; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.